Drug Type Universal CAR-T |
Synonyms TAA3UCAR T, TAA3UCARg T, TAA3UCARgamma delta T cell therapy + [2] |
Target |
Action inhibitors |
Mechanism Tumor-associated antigen inhibitors(Tumor-associated antigen inhibitors), Gene transference(Gene transference), T lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Preclinical | China | 23 Jun 2022 | |
Solid tumor | Preclinical | China | 23 Jun 2022 |